from
$39.95Buy Healing and Injury Repair Peptides
Sale
Sale
Sale
Sale
Shop Injury Repair Peptides from a Leading Research Supplier
Healius Peptides supplies research peptides for tissue repair, wound healing, and recovery studies to over 30,000 researchers across the US, UK, EU, Canada, Australia, and New Zealand. Every vial is third-party lab-tested to at least 99% purity, shipped with a matched Certificate of Analysis, and dispatched same-day on all orders placed before the cut-off. Shipping is free on orders over the qualifying threshold, and our 4.7-star average rating reflects what returning researchers already know: consistent purity, fast fulfillment, and compliant handling from a leading research peptide supplier.
The Healius injury repair peptide catalog covers eight compounds and blends across five mechanistic classes: tissue regeneration (BPC-157), angiogenesis and matrix remodeling (TB-500), dual-pathway repair (the Wolverine Stack blend), mechano-sensitive repair signaling (MGF), and multi-compound recovery formulations. Every product on this page is sold strictly for laboratory research and in vitro use, is not for human or veterinary administration, and ships with full RUO labeling.
Peptides for Healing: What Researchers Are Investigating
Tissue repair is one of the oldest and most active areas of peptide research. The biological challenge is straightforward: damaged tissue needs to rebuild its structural matrix, restore blood supply, manage inflammation, and recruit the right cell populations to the injury site. What makes peptides valuable in this field is their ability to target individual stages of that process with high precision, giving researchers the tools to study each repair mechanism in isolation or in combination.
Healius stocks eight injury repair peptides and blends that span tissue regeneration, wound closure, anti-inflammatory signaling, matrix reconstruction, and mechano-sensitive repair pathways. The range includes two of the most widely researched healing compounds in the published literature (BPC-157 and TB-500), their combination blend (commonly known as the wolverine stack), a mechano growth factor for damage-response studies, and multi-compound formulations for researchers running combination repair protocols.
Every compound is tested under strict US and UK quality control measures, verified to exceed 99% purity by HPLC, and supported by independent third-party analysis with a batch-specific Certificate of Analysis. Individual product pages contain full specifications, published research references, and preparation guidance.
Injury Repair Peptides by Research Application
Healing research spans everything from tendon and ligament repair to gut mucosal protection to post-surgical wound closure. The eight compounds below are grouped by their primary research application in the injury and recovery literature.
Tissue Repair and Regeneration Peptides
BPC-157 is a 15-amino acid synthetic peptide derived from a protective protein found in human gastric juice. It is the single most-searched research peptide that Healius supplies, and its published research profile in injury and repair models is extensive. Studies have investigated BPC-157 for its effects on tendon-to-bone healing, ligament repair, muscle crush injury recovery, gut mucosal protection, and blood vessel formation at injury sites. Its mechanism has been linked in the published literature to modulation of the nitric oxide system, growth factor upregulation (including VEGF and EGF), and activation of the FAK-paxillin pathway. For researchers studying tissue repair at almost any anatomical site, BPC-157 is typically the first compound considered.
TB-500 (Thymosin Beta-4) is a 43-amino acid peptide that plays a central role in actin regulation and cell migration. In injury research, its significance comes from its documented ability to promote the movement of repair cells toward damaged tissue. Published studies have examined TB-500 for its effects on wound closure speed, new blood vessel formation in ischemic tissue, modulation of the inflammatory response, and reduction of scar tissue. Whereas BPC-157 tends to appear in research focused on specific tissue types (tendons, gut, muscle), TB-500’s published profile is broader, with studies spanning cardiac tissue, corneal injury, dermal wounds, and models of neurological damage.
Wound Healing and Matrix Repair Peptides
GHK-Cu (Copper Peptide) appears across multiple categories on this site, and its relevance to injury repair centers on wound healing and structural tissue reconstruction. Published research has documented GHK-Cu’s effects on wound contraction rates, the recruitment of fibroblasts and immune cells to injury sites, and the rebuilding of damaged extracellular matrix through upregulated collagen and glycosaminoglycan synthesis. In injury models, GHK-Cu has been studied for its capacity to accelerate the transition from the inflammatory phase to the remodeling phase of wound repair, a distinct research angle from its cosmetic applications.
KPV (Lysine-Proline-Valine) is an anti-inflammatory tripeptide fragment that has been studied in injury contexts where excessive inflammation impedes healing. Published research on KPV in injury models has focused on mucosal tissue, particularly gut lining inflammation and damage, where its documented NF-kB suppression and reduction in pro-inflammatory cytokines have been investigated as mechanisms for creating an environment in which repair processes can proceed without being overwhelmed by the inflammatory response. For researchers studying injuries in which inflammation is the primary barrier to recovery, KPV targets that bottleneck.
Mechano-Sensitive Repair Peptides
PEG MGF (PEGylated Mechano Growth Factor) is a PEGylated form of the IGF-1Ec splice variant that the body produces in response to tissue loading and mechanical damage. Its relevance to injury repair is distinct from the muscle hypertrophy angle covered elsewhere on this site. In injury research, PEG MGF has been investigated for its role in initiating the earliest stages of tissue repair following mechanical trauma, specifically in recruiting precursor cells to the damage site and in the signaling cascade that begins the regeneration process before the tissue transitions into remodeling. Researchers studying the acute repair response to mechanical injury, rather than long-term growth, tend to find PEG MGF relevant for its role at the very start of the healing timeline.
Injury Repair Peptide Blends: The Wolverine Stack and Beyond
Injury repair research increasingly involves multi-compound protocols that target different stages of the healing process simultaneously. The three blends below combine complementary repair peptides in pre-mixed formulations.
BPC-157 + TB-500 Blend (The Wolverine Stack) is the most widely recognized peptide combination in the injury repair research community. The name comes from the regenerative connotation: BPC-157 delivers tissue-specific repair signaling, growth-factor upregulation, and nitric oxide modulation, while TB-500 delivers actin-mediated cell migration, blood-vessel formation, and anti-inflammatory activity. Published research on each component supports its complementary mechanisms, and the blend has become a standard starting point for researchers designing multi-target healing protocols. It is available as a single pre-mixed vial with consistent component ratios.
Buy BPC-157 + TB-500 Blend (Wolverine Stack)
Glow Blend (BPC-157, TB-500 & GHK-Cu) extends the wolverine stack by adding GHK-Cu’s matrix repair and wound contraction signaling. This three-compound blend covers tissue regeneration (BPC-157), cell migration and inflammation management (TB-500), and extracellular matrix reconstruction (GHK-Cu). Researchers studying wound healing outcomes that depend on both cellular repair and structural matrix rebuilding have used this combination to investigate whether the three mechanisms together produce different healing trajectories than any single compound or pair.
Klow Blend (BPC-157, TB-500, KPV & GHK-Cu) is the most comprehensive repair blend Healius supplies. It adds KPV’s anti-inflammatory cytokine suppression to the Glow Blend formula, creating a four-pathway combination that addresses tissue repair, cell migration, matrix remodeling, and inflammatory control in a single formulation. For researchers working on injury models in which chronic or excessive inflammation is a significant variable, the Klow Blend provides a way to investigate whether adding targeted anti-inflammatory signaling alongside repair compounds alters the overall healing outcome.
How Do Healing Peptides Work in Research?
Injury repair is not a single biological event. It is a sequence of overlapping phases, and the peptides in this catalog each target different points in that sequence. Understanding which phase your research focuses on determines which compound is most relevant.
The inflammatory phase is the body’s immediate response to tissue damage. Inflammation clears debris and recruits immune cells, but if it persists too long, it blocks the transition to repair. KPV targets this phase by suppressing NF-kB-mediated pro-inflammatory signaling, and TB-500 contributes to its anti-inflammatory effects in addition to its cell-migration activity. Researchers studying healing failures caused by excessive or chronic inflammation typically start with one or both of these compounds.
The proliferative phase is where new tissue actually forms. BPC-157 and TB-500 are the most studied peptides for this phase. BPC-157 has been investigated for its ability to upregulate growth factors (VEGF, EGF, FGF) that drive new blood vessel formation and cell proliferation at the injury site. TB-500 promotes the migration of endothelial cells and keratinocytes toward the wound by modulating actin polymerization. PEG MGF enters the picture here as well, specifically in mechano-sensitive tissues where the damage signal itself triggers the IGF-1Ec splice variant response.
The remodeling phase is the final stage, where provisional repair tissue is replaced with organized, functional tissue. GHK-Cu is the primary research compound for this phase, with published studies documenting its effects on collagen organization, elastin deposition, glycosaminoglycan synthesis, and metalloproteinase activity. The transition from disorganized scar-like tissue to structured functional tissue is where GHK-Cu’s research profile is strongest.
Best Peptides for Healing and Recovery: Choosing the Right Compound
Eight compounds across three healing phases give you a lot of flexibility. Here is how to match them to your research question.
If your research targets tendon, ligament, gut, or general soft-tissue repair, BPC-157 has the strongest published evidence base. It is the default starting compound for most tissue-healing studies and the most frequently referenced peptide in the injury repair literature.
If your research targets wound closure, cell migration, and blood vessel formation at injury sites, TB-500 is the most relevant compound. Its actin-regulation mechanism drives the physical movement of repair cells toward damaged tissue, distinct from BPC-157’s growth-factor signaling approach.
If your research targets multi-pathway healing using the most established combination, the BPC-157 + TB-500 Blend (wolverine stack) brings both mechanisms into a single protocol. The Glow Blend adds matrix remodeling via GHK-Cu. The Klow Blend adds anti-inflammatory control via KPV on top of that.
If your research targets inflammation as a barrier to healing, KPV directly suppresses the NF-kB pathway. It is the most focused anti-inflammatory compound in this category and is particularly relevant to research on mucosal and gut tissue injury.
If your research targets the acute mechano-sensitive repair response to physical tissue damage, PEG MGF targets the earliest signaling events following mechanical trauma, before the tissue transitions into proliferation and remodeling.
If your research targets matrix remodeling, scar tissue organization, and structural tissue reconstruction, GHK-Cu has the most relevant published profile for the late-stage remodeling phase of wound healing.
Need help matching compounds to a specific injury model? Our research support team can discuss published references, preparation guidance, and protocol considerations for any product we supply.
Buy Injury Repair Peptides with Verified 99% Purity.
Healing research depends on consistent, high-purity compounds. Sequence errors or contaminants in a repair peptide can trigger off-target inflammatory responses and invalidate weeks of work. Healius eliminates that risk at the source.
99%+ purity on every batch, no exceptions. HPLC and mass spectrometry confirm purity, molecular weight, and sequence accuracy before anything leaves our facility.
Every batch is independently verified. A third-party laboratory runs its own analysis in parallel with ours. The combined data is published in the Certificate of Analysis included with your shipment.
GMP and ISO 9001:2015 quality frameworks. Testing, quality control, and fulfillment are conducted across our US and UK operations to pharmaceutical-grade standards.
Fast, tracked shipping worldwide. Order before 2 pm and your peptides will ship that same business day. Tracked delivery is available to the US, UK, EU, and Australia.
Full preparation support. Our Reconstitution Calculator handles dilution volumes for every compound, and the Reconstitution and Storage Guide provides handling and storage instructions across all formats.
Browse All Injury Repair Peptides
Frequently Asked Questions
Injury repair peptides are synthetic compounds studied in published research for their effects on tissue healing, wound closure, inflammation management, cell migration, and matrix reconstruction. They target specific phases of the biological repair process and are used in research models spanning tendon, ligament, muscle, gut, skin, and vascular tissue. All injury repair peptides sold by Healius Peptides are for in vitro research use only.
The wolverine stack is a common name for the combination of BPC-157 and TB-500 in a single research protocol. BPC-157 contributes tissue repair signaling through growth factor upregulation and nitric oxide modulation, while TB-500 contributes cell migration and blood vessel formation through actin regulation. Healius supplies this combination as a pre-mixed blend in a single vial with consistent component ratios, eliminating the need to source and combine the two compounds separately.
BPC-157 and TB-500 both appear in injury repair research but target different mechanisms. BPC-157’s published profile centers on growth factor upregulation (VEGF, EGF), nitric oxide system interaction, and tissue-specific repair in tendons, ligaments, gut, and muscle. TB-500 primarily acts by regulating actin, promoting the physical migration of repair cells to injury sites, and supporting the formation of new blood vessels. Many researchers use them in combination (the wolverine stack) because their mechanisms are complementary rather than overlapping.
BPC-157 has the most extensive published evidence base for tendon and ligament repair research. Studies have investigated its effects on tendon-to-bone healing, Achilles tendon transection models, and ligament repair in various animal models. TB-500 has also been examined in tendon research for its effects on cell migration and inflammation. The BPC-157 + TB-500 Blend combines both mechanisms for researchers running multi-target tendon healing protocols.
BPC-157 has the strongest research profile in gut tissue models, which is consistent with its origin as a fragment of a gastric juice protein. Published studies have examined its effects on mucosal protection, ulcer healing, and intestinal anastomosis repair. KPV has also been investigated for gut-related inflammation, specifically for its ability to suppress pro-inflammatory cytokine production by modulating the NF-kB pathway in mucosal tissue.
It depends on whether inflammation is a major variable in your injury model. The Glow Blend contains BPC-157, TB-500, and GHK-Cu, covering tissue repair, cell migration, and matrix remodeling. The Klow Blend adds KPV to that formula, providing targeted suppression of anti-inflammatory cytokine production by modulating the NF-kB pathway. If your injury model involves well-controlled inflammation, the three-compound Glow Blend covers the core repair pathways. If chronic or excessive inflammation is slowing healing in your model, the four-compound Klow Blend addresses that bottleneck directly.
Several compounds appear in both the Injury Repair and Muscle Building categories because their research profiles span both applications. PEG MGF, for example, is studied for mechano-sensitive repair signaling in injury models and for satellite cell recruitment in muscle growth research. Researchers designing protocols that involve both tissue damage and subsequent muscle recovery often draw from both categories.
PEG MGF is a PEGylated form of mechano growth factor, a splice variant of IGF-1 produced in response to mechanical tissue damage. In injury repair research, it has been studied for its role in initiating the earliest repair signaling events following physical trauma, specifically the recruitment of precursor cells to the damage site. Its relevance to injury research is limited to the acute response phase rather than to long-term tissue remodeling.
Yes. Published research has examined both BPC-157 and TB-500 in post-surgical healing models, including studies on surgical wound closure, anastomosis repair, and post-operative tissue recovery. GHK-Cu has been investigated for its effects on the remodeling phase of surgical wound healing, particularly the transition from scar tissue to organized functional tissue.
Every batch exceeds 99% purity confirmed by HPLC analysis. Molecular weight and amino acid sequence are verified by mass spectrometry. All batches undergo independent third-party verification, and the results are published in a Certificate of Analysis specific to your order.
Lyophilized vials should be stored at -20 °C for long-term use or refrigerated at 2-8 °C if reconstitution is planned within a few weeks. After adding bacteriostatic water, keep the solution at 2-8 °C and use within the stability window noted on the product page. Avoid freeze-thaw cycling, which can break peptide bonds and compromise purity. Step-by-step instructions are available in our Reconstitution and Storage Guide.
No. BPC-157 is not an FDA-approved drug. It is a research peptide with an extensive published scientific literature base, but has not completed human clinical trials under an approved investigational new drug pathway. BPC-157 was removed from the FDA Section 503A bulk drug substances list for compounding use. The peptide remains widely studied in preclinical research, and Healius supplies BPC-157 exclusively as a research reagent for in vitro laboratory investigation. It is not a therapeutic product and is not intended for human administration.
BPC-157 is listed on the World Anti-Doping Agency (WADA) Prohibited List and is banned under USADA policy for athletes subject to anti-doping jurisdiction. This status applies to competitive athletes and does not reflect the research use of BPC-157 in laboratory settings. Researchers working in the fields of tissue repair and wound healing study BPC-157 in controlled in vitro and animal models, which is separate from the sport-context regulatory framework. Healius sells BPC-157 as an RUO research reagent, not as a performance product, and customers are responsible for compliance with any institutional, sport, or occupational regulations that apply to them.
Published research on BPC-157 has generally reported a favorable safety profile across the pre-clinical literature, with controlled animal studies documenting low toxicity at research-relevant doses. However, pre-clinical data do not translate directly to human safety; there are no completed Phase 2 or Phase 3 human clinical trials, and long-term safety has not been established. BPC-157 remains a research compound with an incomplete clinical safety picture. For that reason, Healius supplies it strictly for in vitro research use and does not make human safety or efficacy claims.
Research-peptide purchasing safety depends entirely on the supplier’s quality standards. Low-quality research peptide suppliers ship products with variable purity, inconsistent sequence verification, or mislabeled compounds. Healius Peptides manages testing, quality control, and fulfillment through our US and UK operations under GMP and ISO 9001:2015 frameworks, publishes a batch-specific Certificate of Analysis for every order, and confirms purity above 99% by HPLC on every batch with independent third-party verification. Our research peptides are supplied for in vitro laboratory use and are not intended for human administration by any route.
No. All Healius Peptides products are sold for in vitro research use only. Products must not be used in human or animal trials, administered to humans or animals, or supplied to any third party for human investigational use.
Join 35,000+ researchers
Subscriber-only pricing, new peptide drops, restock alerts, and fresh lab data delivered before anyone else.